6th Microbiome Movement - Drug Development Summit Europe
Evvnt Promotion / evvnt
Archivio
25.01.2022 - 27.01.2022 Online, United Kingdom
Time: 10:00 AM - 5:50 PM
Temi della conferenza
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Informazioni ed Iscrizioni:
https://go.evvnt.com/919896-2?pid=4832
Ms. Emily Lincoln
Medicina General
Lingua
Inglese
Inglese
Quote del Congresso
Drug Developer - Conference Only (digital) GBP 1549.00, Academic - Conference Only (digital) GBP 1299.00, Solution & Service Provider - Conference Only (digital) GBP 1899.00
Drug Developer - Conference Only (digital) GBP 1549.00, Academic - Conference Only (digital) GBP 1299.00, Solution & Service Provider - Conference Only (digital) GBP 1899.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
